CLINICAL PAIN NEUROSCIENTIST TALKS ABOUT HOW THE BRAIN PROCESSES PAIN INFORMATION Trial: affects on pain and activity levels, by educating knee osteoarthritis participants in individualised exercise programs
With
Tasha Stanton,
Associate Professor of Clinical Pain Neuroscience
Group, Leader Persistent Pain Research Group (Lifelong Health)
SAHMRI (South Australian Health and Medical Research Institute) &
co-Director of IMPACT in Health, University of South Australia
SEGMENT
Filmed in Adelaide | March 2026
The Persistent Pain Research Group’s vision is to work hand-in-hand with consumers to undertake impactful research that helps better understand and treat persistent pain.
Their studies span discovery to implementation science to determine key contributors to the development and maintenance of persistent pain and to use this information to create novel brain-based interventions.
They hold expertise in developing new technologies, such as virtual and mediated reality, and translating these technologies to the clinical environment, using innovative co-design methods.
The Persistent Pain Research Group studies a variety of painful conditions, with specific focus on:
- Osteoarthritis
- Spinal pain (neck and back)
- Complex regional pain syndrome
- Phantom limb pain after amputation
Persistent pain affects one in five Australians and costs the nation an estimated $73 billion per year in health system costs, lost productivity and other financial costs.
Persistent pain also has debilitating personal costs – negatively impacting quality of life and the ability to engage in meaningful work and life activities.
Despite the enormity of this problem, very few effective treatments exist with most showing only small to moderate improvements. New treatments are desperately needed. The group believes the best way to create impactful change is to work with people with lived experience of persistent pain to devise solutions with them, not for them.
Source: SAHMRI webpage Persistent Pain Research Group
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
-
Psychiatrists to discuss connectedness at RANZCP 2023 Congress
Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
-
Fulfilling clinical, academic & research goals in General Practice
Dr Ramya Raman is a Specialist General Practitioner, medical educator, and health policy leader. Raised in Orange in Central West NSW, where she lived for over 15 years, she brings a deep, lived understanding of rural and community healthcare to her work.
